Home World News Europe Czech Republic Prague Examiner OpenAI and the FDA are reportedly discussing AI for drug evaluations
Prague Examiner

OpenAI and the FDA are reportedly discussing AI for drug evaluations

OpenAI and the FDA are reportedly discussing AI for drug evaluations thumbnail

OpenAI has met with officials from the U.S. Food and Drug Administration (FDA) to discuss the agency’s use of AI to speed up drug evaluations, Wired reported on Wednesday. According to the report, OpenAI and the FDA have discussed a project called cderGPT, which seems to be an AI tool for the Center for Drug […]

OpenAI and the FDA are reportedly discussing AI for drug evaluations

OpenAI has met with officials from the U.S. Food and Drug Administration (FDA) to discuss the agency’s use of AI to speed up drug evaluations, Wired reported on Wednesday. According to the report, OpenAI and the FDA have discussed a project called cderGPT, which seems to be an AI tool for the Center for Drug […]

Read More

Tags:

Read More

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Jack Dorsey and Elon Musk would like to ‘delete all IP law’

Jack Dorsey, co-founder of Twitter (now X) and Square (now Block), sparked...

Access to future AI models in OpenAI’s API may require a verified ID

OpenAI may soon require organizations to complete an ID verification process in...

UK founders grow frustrated over dearth of funding: ‘the problem is getting worse’

According to Dealroom data cited by the Financial Times, British start-ups raised...

A fresh $100M rolls into Dig Ventures as it bids to woo early&stage European startups

The number of “operator VCs” — former founders turned VCs — has...